What does the future hold for robotics in medicine?
Medical experts from Weill Cornell Medicine discuss this fascinating topic. Joining us for this panel are Cheguevara Afaneh, MD; T. Sloane Guy, MD; Jim Hu, MD; Jeffrey Port, MD; Douglas Scherr, MD; and Joel Stein, MD, with moderator Dr. Max Gomez from WCBS-TV.
The past decade has produced tremendous advances in the use of robotics across clinical areas, vastly expanding the horizons of disease management.
Dr. Timothy McClure joined Brady Urology as a full time faculty member during the summer of 2016, providing his expertise to both the Departments of Urology & Radiology. Dr. McClure is an expert in imaging, image-guided therapy, and the minimally invasive treatment of urologic disease. Dr. McClure brings a unique training background to the department as he is not only a urologist, but also a board-certified radiologist who is fellowship trained in vascular and interventional radiology. Dr.
The LeFrak Center for Robotic Surgery is home to a partnership between the most technologically-advanced surgical robots and the most experienced and dedicated surgical team. The Center is led by the internationally renowned surgeon, Dr. Jim C.
Urologic oncology is a multidisciplinary field that incorporates innovative surgical technology, systemic treatments such as chemotherapy, as well as a focused research effort. As a Professor of Urology and the Clinical Director of Urologic Oncology, I continually interact with colleagues in the areas of medical oncology, radiation oncology, and pathology, among others, in order to provide the most comprehensive and innovative care for our patients with prostate, bladder, kidney and testicular cancer.
Men are three to four times more likely than women to be diagnosed with bladder cancer. The most common type of bladder cancer is transitional cell carcinoma, comprising 90% of all bladder cancers. Transitional cell carcinomas are staged according to the depth of bladder wall invasion, which also has bearing on treatment options. Superficial transitional cell carcinomas are in the lining of the bladder and have not invaded the deeper bladder muscle wall, whereas muscle invasive cancers have penetrated this layer and are more likely to spread.
The Brady Urologic Health Center is located within an 8,000 square foot suite on the ninth floor of the Starr Pavilion at Weill Cornell Medicine/New York-Presbyterian Hospital and is composed of a close-knit team of physicians, working together to provide treatment for the broad spectrum of urologic conditions.